Acute myeloid leukemia: update in diagnosis and treatment in Brazil-Reference-Cited by-同舟云学术

Acute myeloid leukemia: update in diagnosis and treatment in Brazil

Published:2011-06 Issue:2 Volume:9 Page:179-183
ISSN:1679-4508
Container-title:Einstein (São Paulo)
language:
Short-container-title:Einstein (São Paulo)

Author:

Helman Ricardo¹,Santos Fabio Pires de Souza¹,Simões Belinda²,Atta Elias Hallack³,Callera Fernando⁴,Dobbin Jane de Almeida⁵,Mattos Éderson Roberto⁶,Atalla Angelo⁷,Maiolino Angelo⁸,Zanichelli Maria Aparecida⁹,Diefenbach Cristiane Fração¹⁰,Delamain Marcia Torresan¹¹,Hamerschlak Nelson¹

Affiliation:

1. Hospital Israelita Albert Einstein – HIAE, Brazil

2. Universidade de São Paulo – USP, Brazil

3. Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti – HEMORIO, Brazil

4. Hospital Pio XII, Brazil

5. Instituto Nacional do Câncer – INCA, Brazil

6. Hospital Amaral Carvalho - Jaú, Brazil

7. Universidade Federal de Juiz Fora – UFJF, Brazil

8. Universidade Federal do Rio de Janeiro – UFRJ, Brazil

9. Estado de São Paulo Dr. Euryclides de Jesus Zerbini, Brazil

10. Hospital Universitário de Santa Maria, Brazil

11. Universidade Estadual de Campinas – UNICAMP, Brazil

Abstract

Objective: To identify how the Brazilian hematology centers treated and diagnosed cases of acute myeloid leukemia in 2009. Methods: An epidemiological observational multicenter study of 11 listed Brazilian centers that treat acute myeloid leukemia and perform bone marrow transplantation. Data were collected from clinical charts of patients with acute myeloid leukemia treated at the said centers between 2005 and 2009. The availability for immunophenotyping and cytogenetic tests was assessed. Results: During 2009, a total of 345 new cases of acute myeloid leukemia were diagnosed. Differences were noted in the tests performed between patients who initiated treatment at the center and those referred for treatment. Of the participating centers, 72% conducted some type of molecular study in acute myeloid leukemia upon diagnosis. Conclusion: Treatment for acute myeloid leukemia in Brazil shows significantly inferior results when compared to other centers worldwide.

Publisher

FapUNIFESP (SciELO)

Subject

General Medicine

Link

http://www.scielo.br/pdf/eins/v9n2/1679-4508-eins-9-2-0179.pdf

Reference23 articles.

1. The molecular basis of leukemia;Gilliland DG;Hematology Am Soc Hematol Educ Program,2004

2. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues;Swerdlow SH,2008

3. Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Councils 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the Medical Research Council;Hann IM;Blood,1997

4. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European Leukemia Net;Döhner H;Blood

5. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia;Cheson BD;J Clin Oncol,2003

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcome and prognosis of patients with acute myeloid leukemia submitted to chemotherapy with 5 years of follow-up;Hematology, Transfusion and Cell Therapy;2022-12

2. Overall survival of Brazilian acute myeloid leukemia patients according to the European LeukemiaNet prognostic scoring system: a cross-sectional study;Medical Oncology;2018-09-05